Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SRC | P12931 | 1/20 | 0.65 |
| ▸ | ACP3 | P15309 | 3/20 | 0.56 |
| ▸ | PGK1 | P00558 | 8/20 | 0.48 |
| ▸ | PGK2 | P07205 | 8/20 | 0.48 |
| ▸ | PTPN5 | P54829 | 4/20 | 0.41 |
| ▸ | MMP8 | P22894 | 1/20 | 0.41 |
| ▸ | MMP14 | P50281 | 1/20 | 0.41 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9301497 | 0.92 | SRC (0.75) | SRCACP3PGK1PGK2 | |
| SCHEMBL5936840 | 0.82 | SRC (0.62) | SRCACP3PGK1PGK2CA14 | |
| SCHEMBL4093802 | 0.80 | SRC (0.60) | SRCPGK1PGK2MMP8MMP14 | |
| SCHEMBL1552133 | 0.80 | SRC (0.60) | SRCACP3PGK1PGK2MMP8 | |
| SCHEMBL744205 | 0.80 | SRC (0.60) | SRCACP3PGK1PGK2CA14 | |
| SCHEMBL9004470 | 0.80 | POLB (0.46) | SRCACP3PTPN5MMP8MMP14 | |
| SCHEMBL4094661 | 0.79 | SRC (1.00) | SRCACP3PGK1PGK2 | |
| Water SCHEMBL9146143 | 0.77 | SRC (0.56) | SRCPGK1PGK2MMP8MMP14 | |
| SCHEMBL15534136 | 0.75 | SRC (0.54) | SRCACP3PGK1PGK2 | |
| SCHEMBL9316994 | 0.75 | SRC (0.54) | SRCACP3PGK1PGK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2141545-A1 | Phosphonate containing photoconductors | Xerox Corporation (US) | 2010-01-06 | — | — | EP | claimed |
| EP-2128709-A1 | Phosphonate Hole Blocking Layer Photoconductors | Xerox Corporation (US) | 2009-12-02 | — | — | EP | claimed |
| US-7973109-B2 | Crosslinked type layered metal phosphonate compound, production process therefor, non-crosslinked type layered metal phosphonate compound, production process therefor, as well as stock solution | KABUSHIKI KAISHA TOYOTA CHUO KENKYUSHO (JP) | 2011-07-05 | — | — | US | disclosed |
| EP-2141545-A1 | Phosphonate containing photoconductors | Xerox Corporation (US) | 2010-01-06 | — | — | EP | disclosed |
| EP-2128709-A1 | Phosphonate Hole Blocking Layer Photoconductors | Xerox Corporation (US) | 2009-12-02 | — | — | EP | disclosed |
| US-20090093607-A1 | Crosslinked type layered metal phosphonate compound, production process therefor, non-crosslinked type layered metal phosphonate compound, production process therefor, as well as stock solution | KABUSHIKI KAISHA TOYOTA CHUO KENKYUSHO (JP) | 2009-04-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090093607-A1 | Crosslinked type layered metal phosphonate compound, production process therefor, non-crosslinked type layered metal phosphonate compound, production process therefor, as well as stock solution | WEE1, WEE2, PPIP5K2 | SRC 2441/4885ACP3 3218/4885PGK1 784/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.